This award recognises Cell Signaling Technology as the company with the most antibody citations during 2017 based on data from CiteAb.

From the data generated through CiteAb, we are able to gain a really clear picture of the way antibodies are used around the world. We can tell which countries are investing most in research using antibodies, which companies are seeing growth or decline, which antibodies are most successful and which areas of research are seeing growth.

Dr Andrew Chalmers, Founder of CiteAb, said: “This is an esteemed award which recognises Cell Signaling Technology as the most successful antibody company based on our data from CiteAb. This is no mean feat which would not have happened without the company offering a large number of products that help researchers make novel findings, and without a huge amount of effort from everybody at Cell Signaling Technology. We wholeheartedly congratulate you all on your achievement.”

View past winners